HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. 1987

J S Smolen, and J H Klippel, and E Penner, and M Reichlin, and A D Steinberg, and T M Chused, and O Scherak, and W Graninger, and E Hartter, and C C Zielinski

HLA-DR antigens and autoantibodies to the nuclear or cytoplasmic antigens Ro/SSA, La/SSB, Sm, and RNP were determined in North American and Austrian patients with systemic lupus erythematosus (SLE). Analysis of the association of antibodies to these ribonucleic acid (RNA)-protein antigens with HLA-DR antigens showed that HLA-DR3 was related to the presence of anti-Ro/SSA or anti-La/SSB, or both. In contrast, anti-Sm or anti-RNP, or both were associated with HLA-DR4. HLA-DR5 was associated with absence of these autoantibodies. The data extend evidence for the complexity and heterogeneity of SLE. Moreover, they indicate that, in SLE, genes linked to those coding for HLA-DR antigens, are related to the specificity of autoantibody responses rather than to the primary immunological abnormalities of this disorder.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009698 Nucleoproteins Proteins conjugated with nucleic acids. Nucleoprotein
D005260 Female Females
D006681 HLA-D Antigens Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. Antigens, HLA-D,Class II Human Antigens,HLA-Dw Antigens,Human Class II Antigens,Ia-Like Antigens, Human,Immune Response-Associated Antigens, Human,Immune-Associated Antigens, Human,Immune-Response Antigens, Human,HLA-D,HLA-Dw,Immune Response Associated Antigens, Human,Antigens, HLA D,Antigens, HLA-Dw,Antigens, Human Ia-Like,Antigens, Human Immune-Associated,Antigens, Human Immune-Response,HLA D Antigens,HLA Dw Antigens,Human Ia-Like Antigens,Human Immune-Associated Antigens,Human Immune-Response Antigens,Ia Like Antigens, Human,Immune Associated Antigens, Human,Immune Response Antigens, Human
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097585 SS-B Antigen Nuclear autoantigens implicated in nascent RNA protection. It is a target of AUTOANTIBODIES in patients with SJOGREN'S SYNDROME. LA Antigen,La(SSB) Antigen,Lupus Antigen La,SS-B La Antigen,Sjogren's Syndrome-B Antigen,SS B Antigen
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J S Smolen, and J H Klippel, and E Penner, and M Reichlin, and A D Steinberg, and T M Chused, and O Scherak, and W Graninger, and E Hartter, and C C Zielinski
December 1983, Arthritis and rheumatism,
J S Smolen, and J H Klippel, and E Penner, and M Reichlin, and A D Steinberg, and T M Chused, and O Scherak, and W Graninger, and E Hartter, and C C Zielinski
January 1991, Clinical and experimental rheumatology,
J S Smolen, and J H Klippel, and E Penner, and M Reichlin, and A D Steinberg, and T M Chused, and O Scherak, and W Graninger, and E Hartter, and C C Zielinski
June 2001, The Korean journal of internal medicine,
J S Smolen, and J H Klippel, and E Penner, and M Reichlin, and A D Steinberg, and T M Chused, and O Scherak, and W Graninger, and E Hartter, and C C Zielinski
January 1986, Immunogenetics,
J S Smolen, and J H Klippel, and E Penner, and M Reichlin, and A D Steinberg, and T M Chused, and O Scherak, and W Graninger, and E Hartter, and C C Zielinski
December 1989, Arthritis and rheumatism,
J S Smolen, and J H Klippel, and E Penner, and M Reichlin, and A D Steinberg, and T M Chused, and O Scherak, and W Graninger, and E Hartter, and C C Zielinski
April 1983, The Journal of rheumatology,
J S Smolen, and J H Klippel, and E Penner, and M Reichlin, and A D Steinberg, and T M Chused, and O Scherak, and W Graninger, and E Hartter, and C C Zielinski
April 1991, British journal of rheumatology,
J S Smolen, and J H Klippel, and E Penner, and M Reichlin, and A D Steinberg, and T M Chused, and O Scherak, and W Graninger, and E Hartter, and C C Zielinski
February 1977, Annals of the rheumatic diseases,
J S Smolen, and J H Klippel, and E Penner, and M Reichlin, and A D Steinberg, and T M Chused, and O Scherak, and W Graninger, and E Hartter, and C C Zielinski
January 1984, Terapevticheskii arkhiv,
J S Smolen, and J H Klippel, and E Penner, and M Reichlin, and A D Steinberg, and T M Chused, and O Scherak, and W Graninger, and E Hartter, and C C Zielinski
May 1979, Archives of dermatological research,
Copied contents to your clipboard!